Holding Off The next big thing in the world of artificial intelligence are so-called "AI agents" — models that are capable of interacting with their environment, like a computer desktop, allowing them to autonomously complete tasks without human intervention.

It’s a company that has become a household name, and a leader in its field. People are even recognizing the name Sam Altman, as representing the ‘Godfather of AI,’ as we move into this era where artificial intelligence has a greater and clearer impact on how we live and work.

Nvidia, Google and hot startup OpenAI are turning to "synthetic data" factories amid demand for massive amounts of data needed to train artificial intelligence models.

Elon Musk’s AI startup, xAI, has launched its first standalone app for Grok, the chatbot designed to challenge giants like OpenAI’s ChatGPT and Google’s Bard.

OpenAI on Friday outlined plans to revamp its structure, saying it would create a public benefit corporation to make it easier to "raise more capital than we'd imagined," and remove the restrictions imposed on the startup by its current nonprofit parent.

Red teaming has become the go-to technique for iteratively testing AI models to simulate diverse, lethal, unpredictable attacks.

Geoffrey Hinton (the Godfather of AI) has seemingly formed an allegiance with Elon Musk and supports the billionaire's lawsuit against OpenAI's evolution into a for-profit entity.

A new blog post by OpenAI CEO Sam Altman indicates that the AI firm knows how to build AGI as it shifts gears and focus to superintelligence.

AI tools to beat writer's block, fill your socials with stunning pics, and endless options for effortless creativity

SearchGPT has the potential to fundamentally change how people seek and discover information. For pharma companies, failing to establish discoverability in this new search space risks missing out on multiple engagement opportunities. Success will depend on creating expert, human-focused content that builds trust and delivers real value.